| Patents for C07J 41 - Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring (4,637) |
|---|
| 03/15/2006 | EP1633367A2 Antiangiogenic agents |
| 03/14/2006 | US7012070 Estrogenic compounds as anti-mitotic agents |
| 03/14/2006 | US7012069 For therapy of heart disease and stroke, Alzheimer's disease, and an inflammatory disorder |
| 03/09/2006 | US20060052594 New corticosteroids |
| 03/08/2006 | EP1631579A2 17beta-hydroxysteroid dehydrogenase inhibitors |
| 03/08/2006 | EP1240179B1 3-methylene steroid derivatives for the treatment of autoimmune diseases |
| 03/07/2006 | US7008900 Double metal cyanide catalysts for producing polyether polyols |
| 03/01/2006 | EP1351972B1 Lipids comprising an aminoxy group |
| 02/23/2006 | WO2006020885A1 Process for the preparation of 3-oximino steroids |
| 02/23/2006 | CA2575138A1 Process for the preparation of 3-oximino steroids |
| 02/16/2006 | US20060035872 Process for the preparation of 3-oximino steroids |
| 02/15/2006 | EP1625143A1 Estratriene derivatives |
| 02/09/2006 | US20060030551 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| 02/09/2006 | CA2574967A1 A process for the preparation of 7.alpha.-alkylated 19-norsteroids |
| 02/08/2006 | EP1456224B1 Industrially applicable process for the sulfamoylation of alcohols and phenols |
| 02/07/2006 | US6995278 Antiangiogenic agents |
| 02/01/2006 | EP1621077A1 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 02/01/2006 | EP1169336B1 Ent-steroids as selectively active estrogens |
| 01/31/2006 | US6993229 Method of making spun optical fiber with low PMD |
| 01/31/2006 | US6992076 Providing sustained systemic concentrations of therapeutic or prophylactic agents such as gamma-aminobutyric acid derivatives following oral adiminstration to animals |
| 01/24/2006 | CA2151561C Hydrazino and hydroxyamino-14.beta.-hydroxyandrostane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same |
| 01/12/2006 | US20060009436 11 beta -Fluoro-7 alpha -{5-[methyl(7,7,8,8,9,9,9-heptafluorononyl)amino]pentyl}-17 alpha -methylestra-1,3,5(10)-triene-3,17 beta -diol N-oxide; antiestrogen compound whose metabolism can be controlled; alveolar macrophages do not build up; oral administration |
| 01/11/2006 | EP1294402B1 Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds |
| 01/10/2006 | CA2425841C Angiostatic steroids |
| 01/03/2006 | US6982329 provides synthetic methodology that may be employed to prepare steroid compounds having specified chemical functionality; steroids containing cyclohexene moiety are oxidized to corresponding alpha , beta -unsaturated ketone |
| 12/29/2005 | US20050288480 Photoactive materials |
| 12/28/2005 | EP1608671A1 Oestrogen derivatives as inhibitors of steroid sulphatase |
| 12/21/2005 | EP1144431B1 16-hydroxyestratrienes as selective estrogens |
| 12/21/2005 | EP0713393B1 Estrogenic compounds as anti-angiogenesis agents |
| 12/15/2005 | WO2005030120A3 Antiangiogenic agents |
| 12/15/2005 | DE102004025986A1 Steroid-Prodrugs mit androgener Wirkung Steroid prodrugs with androgenic effect |
| 12/15/2005 | DE102004025985A1 Estriol- und Estetrol-Prodrugs Estriol and estetrol prodrugs |
| 12/15/2005 | DE102004025966A1 Estradiol-Prodrugs Estradiol prodrugs |
| 12/14/2005 | CN1231493C Amphoteric sterols and the use thereof |
| 12/08/2005 | WO2005116050A1 Steroid-hormone conjugates with polyamines and their therapeutic use as anti-cancer and angiostatic agents |
| 12/08/2005 | WO2005116047A2 2-substituted 17-imino estrogen compounds for cytoprotection |
| 12/08/2005 | CA2566373A1 2-substituted 17-imino estrogen compounds for cytoprotection |
| 12/07/2005 | EP1602662A1 Method of obtaining 17alpha-acetoxy-11beta-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione |
| 12/07/2005 | EP1317439B1 Acid-sensitive compounds, preparation and uses thereof |
| 12/01/2005 | WO2005113576A1 Aminosulphonyl- or aminosulphonylamino-substituted phenyl esters as estriol and estetrol prodrugs |
| 12/01/2005 | WO2005113575A1 Steroid prodrugs with androgenic effect |
| 12/01/2005 | WO2005113574A1 Aminosulphonyl- or aminosulphonylamino-substituted phenyl esters as estradiol prodrugs |
| 12/01/2005 | US20050267086 Compounds and methods for cytoprotection |
| 12/01/2005 | CA2564963A1 Steroid prodrugs with androgenic effect |
| 11/30/2005 | EP1599493A1 2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour action |
| 11/29/2005 | CA2123048C Tetrazole derivatives of bile acids, processes for their preparation and the use of these compounds as medicaments |
| 11/24/2005 | US20050261508 Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the NHE-inhibitory efficacy of compounds |
| 11/22/2005 | US6967255 Phenanthrene compounds |
| 11/17/2005 | US20050256325 Treating 17 beta -[(N,N-dimethylcarbamoyl)thio]carbonyl-6 alpha ,9 alpha-difluoro-11-beta -hydroxy-16 alpha-methyl-17-alpha -propionyloxy-3-oxoandrosta-1,4-diene with an alkali metal carbonate-alcohol system and reacting the product with bromofluoromethane |
| 11/17/2005 | US20050256094 especially those of the 20-spiroxane series; 11,12-epoxy steroid, 4,5-9,11-diepoxy steroid and 12-keto intermediates; Pregn-4-ene-7,21-dicarboxylic acid, 9,11-epoxy-17-hydroxy-3-oxo-,?-lactone, methyl ester, (7a,11a,17a)-; eplerenone or epoxymexrenone; minimum of isolation steps |
| 11/17/2005 | US20050256093 Branched polyamine steroid derivatives |
| 11/16/2005 | EP1594886A1 Antitumoral d-homoestra-1, 3, 5 (10)-trien-3-yl 2-substituted sulfamates |
| 11/16/2005 | EP1594884A1 Antitumoral 18a-homoestra-1,3,5(10)-trien-3-yl 2-substituted sulfamates |
| 11/16/2005 | EP1248768B1 Bile acid-substituted phenyl-alkenoylguanidines, method for producing said phenyl-alkenoylguanidines, use thereof as medicaments or diagnostic reagents and medicaments containing the same |
| 11/09/2005 | EP1019365B1 Novel compositions for the delivery of negatively charged molecules |
| 11/08/2005 | US6962909 Treatment of neovascularization disorders with squalimine |
| 11/03/2005 | DE102004019406A1 17α-Fluorsteroide 17α-fluoro steroids |
| 11/02/2005 | EP1237902B1 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase |
| 10/27/2005 | WO2005100376A1 17α-FLUORO-17β-HYDROXIMINOMETHYL STEROIDS, A METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID COMPOUNDS |
| 10/27/2005 | US20050239712 Pharmaceutically active compound |
| 10/26/2005 | EP1587818A2 17-carbamoyloxy cortisol derivatives as selective glucocorticoid receptor modulators |
| 10/20/2005 | US20050234232 Novel compositions for the delivery of negatively charged molecules |
| 10/13/2005 | WO2005095437A1 Method for producing steroid derivative |
| 10/11/2005 | US6953785 Estra-1,3,5(10)-triene derivatives |
| 10/06/2005 | US20050222434 Acid-sensitive compounds, their preparation and uses |
| 10/06/2005 | US20050222115 Bile acid derived steroidal dimers with novel amphiphilic topology having antifungal activity |
| 10/06/2005 | US20050222105 Nitric ester derivatives of hormones such as progesterone, used for preventing premature labor, increasing cervical dilatation, in hormone replacement therapy, as hypeortensive agents and for treating dysmenorrhea |
| 10/06/2005 | US20050222098 Regulation of meiosis |
| 10/06/2005 | US20050222097 Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity |
| 09/29/2005 | US20050215534 Antiinflammatory agents; asthma; chronic obstructive pulmonary disease; dermatitis; antiallergens; antitumor agents; Aida; antiischemic agents; arrhythmia |
| 09/28/2005 | EP1580192A2 16-Hydroxyestratrienes as selective estrogens |
| 09/27/2005 | US6949561 polycyclic compound comprises sulphamate group attached to one of the ring components, wherein ring is naphtho(2,1-f)quinoline |
| 09/27/2005 | US6949533 use in treating asthma, allergy, arthritis and thrombosis |
| 09/21/2005 | EP1444550B1 Polycarbocyclic derivatives for modification of resist, optical and etch resistance properties |
| 09/21/2005 | CN1671858A Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids |
| 09/21/2005 | CN1671648A Photoactive materials |
| 09/06/2005 | US6939932 Initiator systems, polymerisable compositions, and uses thereof for bonding low surface energy substrates |
| 09/01/2005 | US20050192263 3,15-substituted estrone compounds; treatment of steroid hormone dependent diseases such as breast cancer, colon cancer, endometriosis, benign prostatic hyperplasia |
| 09/01/2005 | US20050191367 Administering a therapeutically effective amount of arsenic compounds, optionally along with other non-arsenic therapeutic agents, to a mammal for treating solid tumors |
| 08/31/2005 | EP1517914B1 9-alpha-substituted estratrienes as selectively active estrogen |
| 08/31/2005 | EP1335928B1 Selective glucocorticoid receptor agonists |
| 08/31/2005 | CN1662549A Glucocorticoid receptor ligands for the treatment of metabolic disorders |
| 08/25/2005 | WO2005077968A2 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity |
| 08/25/2005 | US20050187202 Regioselective and stereoselective oxidation of fused ring systems useful for the preparation of aminosterols |
| 08/25/2005 | DE19540233B4 Sulfamat-Derivate von 1,3,5(10)-Estratrien-Derivaten, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen Containing sulphamate derivatives of 1,3,5 (10) -estratrien-derivatives, processes for their preparation and pharmaceutical compositions comprising these compounds |
| 08/25/2005 | CA2552843A1 Steroids for cancer treatment |
| 08/24/2005 | EP1272505B1 8beta-substituted-11beta-pentyl- and 11beta-hexyl-estra-1,3,5(10)-triene derivatives |
| 08/24/2005 | CN1659181A 9-alpha-substituted estratrienes as selectively active estrogens |
| 08/23/2005 | US6933383 Oxidizing only a primary hydroxy on a fused ring to form an aldehyde, leaving the secondary OH alone; sulfating with pyridine:SO3 the primary OH on a fused ring leaving the secondary OH alone. |
| 08/11/2005 | US20050176976 GABA a modulating neurosteroids |
| 08/11/2005 | US20050176952 Phenanthrene compounds |
| 08/11/2005 | US20050176694 steroids such as (11 beta )-11-17-dihydroxy-21-[N-acetyl-S-(4-nitroxybutyroyl) cisteinyloxy]pregne-1,4-diene-3,20-dione having antiinflammatory, immunodepressive and angiostatic activity |
| 08/10/2005 | CN1653083A Deoxycholic acid derivatives for the treatment of acute dysfunctions of portal and hepatic venous circulation |
| 08/10/2005 | CN1214039C 3-nitrogen-6,7-dioxygen steroids and uses thereof |
| 08/10/2005 | CN1214038C 9alpha-chloro-6alpha-fluoro-17alpha-16-methyl-17-beta-methoxy carbonyl-androst-1, 4-dienes esterified in position 17 alpha by a cyclic acyl proup |
| 08/04/2005 | WO2005070950A1 Di-steroidal prodrugs of ethinyl estradiol |
| 08/04/2005 | US20050171075 Substitued 19-nor-cholestenes; antineoplastic agents, wound healing agents, antiinflammatory agents; autoimmune diseases, transplant rejection inhibition, hyperplasia, graft versus host disease; increased cell growth modulation and differentiation, low calcemic activity |
| 08/04/2005 | CA2553816A1 Di-steroidal prodrugs of ethinyl estradiol |
| 08/03/2005 | EP1287017B1 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity |
| 07/28/2005 | US20050164991 7-Oxo-DHEA compounds for treating keratinous conditions/afflictions |